Vesper Bio ApS
PrivateLast Round
Series A
Oct 31, 2025
Total Funding Raised
$5.7M
Company Overview
Vesper Bio ApS is a clinical-stage biotechnology company that develops small-molecule sortilin inhibitors as oral treatments for neurodegenerative and neuropsychiatric diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vesper Bio ApS Comparables
Compare Vesper Bio ApS with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sortina Pharma | 83% | |
| Arkuda Therapeutics | 80% | |
| Alector | 77% | |
Vesper Bio ApS Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 31, 2025 | ||||
| Grant | Oct 14, 2025 | ||||
| Grant | Jan 23, 2024 | ||||
| Seed | Oct 20, 2015 |
Vesper Bio ApS Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Association for Frontotemporal Degeneration | Grant |
| The Michael J. Fox Foundation for Parkinson's Research | Grant |
| Alzheimer's Drug Discovery Foundation | Grant |
Vesper Bio ApS Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Vesper Bio ApS's valuation, stock price, and market status.